FIGURE
Fig. 4
- ID
- ZDB-FIG-211112-13
- Publication
- Zheng et al., 2021 - SARS-CoV-2 spike protein causes blood coagulation and thrombosis by competitive binding to heparan sulfate
- Other Figures
- All Figure Page
- Back to All Figure Page
Fig. 4
HS/heparin treatment can reduce the coagulation caused by S protein. (A, B) The effect of HS and heparin (Hep) co-injection with S trimer on bleeding time; ****, P < 0.0001. (C) The frequency (F) of thrombosis happened in capillaries (DLAV, ISV and CVP), large vessels including artery and vein (DA, PCV), and both capillaries and large vessels (DIC + DP). |
Expression Data
Expression Detail
Antibody Labeling
Phenotype Data
Phenotype Detail
Acknowledgments
This image is the copyrighted work of the attributed author or publisher, and
ZFIN has permission only to display this image to its users.
Additional permissions should be obtained from the applicable author or publisher of the image.
Reprinted from International journal of biological macromolecules, 193(Pt B), Zheng, Y., Zhao, J., Li, J., Guo, Z., Sheng, J., Ye, X., Jin, G., Wang, C., Chai, W., Yan, J., Liu, D., Liang, X., SARS-CoV-2 spike protein causes blood coagulation and thrombosis by competitive binding to heparan sulfate, 1124-1129, Copyright (2021) with permission from Elsevier. Full text @ Int. J. Biol. Macromol.